The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Achillion Pharmaceuticals In | COM | 00448Q201 | 35,201 | 7,839,766 | SH | SOLE | 1 | 7,839,766 | 0 | 0 | |
| Agenus Inc | COM NEW | 00847G705 | 18,604 | 4,218,520 | SH | SOLE | 1 | 4,218,520 | 0 | 0 | |
| Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 73,236 | 623,338 | SH | SOLE | 1 | 623,338 | 0 | 0 | |
| Arbutus Biopharma Corp | COM | 03879J100 | 32,651 | 5,266,280 | SH | SOLE | 1 | 5,266,280 | 0 | 0 | |
| argenx SE | SPONSORED ADR | 04016X101 | 563 | 24,906 | SH | SOLE | 1 | 24,906 | 0 | 0 | |
| Atara Biotherapeutics Inc | COM | 046513107 | 10,857 | 656,018 | SH | SOLE | 1 | 656,018 | 0 | 0 | |
| Avexis Inc | COM | 05366U100 | 45,237 | 467,667 | SH | SOLE | 1 | 467,667 | 0 | 0 | |
| BioCryst Pharmaceuticals | COM | 09058V103 | 17,421 | 3,324,705 | SH | SOLE | 1 | 3,324,705 | 0 | 0 | |
| bluebird bio Inc | COM | 09609G100 | 14,295 | 104,078 | SH | SOLE | 1 | 104,078 | 0 | 0 | |
| Bovie Medical Corp | COM | 10211F100 | 3,852 | 1,139,600 | SH | SOLE | 1 | 1,139,600 | 0 | 0 | |
| Bristol Myers Squibb Co | COM | 110122108 | 52,746 | 827,512 | SH | SOLE | 1 | 827,512 | 0 | 0 | |
| Corium Intl Inc | COM | 21887L107 | 18,564 | 1,675,479 | SH | SOLE | 1 | 1,675,479 | 0 | 0 | |
| Dicerna Pharmaceuticals Inc | COM | 253031108 | 11,954 | 2,078,991 | SH | SOLE | 1 | 2,078,991 | 0 | 0 | |
| Global Blood Therapeutics In | COM | 37890U108 | 817 | 26,310 | SH | SOLE | 1 | 26,310 | 0 | 0 | |
| La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 36,321 | 1,044,307 | SH | SOLE | 1 | 1,044,307 | 0 | 0 | |
| Masimo Corp | COM | 574795100 | 10,465 | 120,900 | SH | SOLE | 1 | 120,900 | 0 | 0 | |
| Myokardia Inc | COM | 62857M105 | 10,882 | 253,962 | SH | SOLE | 1 | 253,962 | 0 | 0 | |
| OraSure Technologies Inc | COM | 68554V108 | 12,053 | 535,707 | SH | SOLE | 1 | 535,707 | 0 | 0 | |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | 17,344 | 1,032,370 | SH | SOLE | 1 | 1,032,370 | 0 | 0 | |
| PTC Therapeutics Inc | COM | 69366J200 | 69,938 | 3,495,143 | SH | SOLE | 1 | 3,495,143 | 0 | 0 | |
| Regenxbio Inc | COM | 75901B107 | 50,710 | 1,539,005 | SH | SOLE | 1 | 1,539,005 | 0 | 0 | |
| SENSUS HEATLHCARE INC | *W EXP 06/08/201 | 81728J117 | 90 | 155,000 | SH | SOLE | 1 | 155,000 | 0 | 0 | |
| Spring Bk Pharmaceuticals In | COM | 849431101 | 4,195 | 249,095 | SH | SOLE | 1 | 249,095 | 0 | 0 | |
| Tactile Sys Technology Inc | COM | 87357P100 | 10,932 | 353,216 | SH | SOLE | 1 | 353,216 | 0 | 0 | |
| Viewray Inc | COM | 92672L107 | 5,878 | 1,020,462 | SH | SOLE | 1 | 1,020,462 | 0 | 0 | |
| Viveve Med Inc | COM NEW | 92852W204 | 7,719 | 1,473,028 | SH | SOLE | 1 | 1,473,028 | 0 | 0 | |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | 1,672 | 200,000 | SH | SOLE | 1 | 200,000 | 0 | 0 | |